Paper · 877134
Dissociation between the adjuvant vs mitogenic activity of a synthetic muramyl dipeptide for murine splenocytes.
Specter S and 2 others. Proc Soc Exp Biol Med, 1977. Cited by 49 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Dissociation between the adjuvant vs mitogenic activity of a synthetic muramyl dipeptide for murine splenocytes. Papers, record 877134. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/877134
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dissociation between the adjuvant vs mitogenic activity of a synthetic muramyl dipeptide for murine splenocytes.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adjuvants, Immunologic | Major topic |
| Antibody Formation | Major topic |
| Dipeptides | Major topic |
| Lymphocyte Activation | Major topic |
| Mitogens | Major topic |
| Animals | |
| Cells, Cultured | |
| Lipopolysaccharides | |
| Male | |
| Mice | |
| Polysaccharides, Bacterial | |
| Spleen | |
| Structure-Activity Relationship |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 17,422,948 | Adjuvants et stimulants de l'immunité: propriétés immunorégulatrices du muramyl-dipeptide, des corynébactéries anaérobies et du diéthyldithiocarbamate de sodium. | Can Vet J | 1988 | https://conductscience.org/library/papers/17422948 | PubMed |
| 9,000,596 | Transplantable rat thyroid cancer cell line FRTC transformed with muramyl dipeptide. | Br J Cancer | 1997 | https://conductscience.org/library/papers/9000596 | PubMed |
| 7,439,991 | Effects of treatment with muramyl dipeptide and certain of its analogs on resistance to Listeria monocytogenes in mice. | Infect Immun | 1980 | https://conductscience.org/library/papers/7439991 | PubMed |
| 7,216,470 | Effects of muramyl dipeptide treatment on resistance to infection with Toxoplasma gondii in mice. | Infect Immun | 1981 | https://conductscience.org/library/papers/7216470 | PubMed |
| 7,054,119 | Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice. | Infect Immun | 1982 | https://conductscience.org/library/papers/7054119 | PubMed |
| 7,035,868 | Muramyl peptides. Chemical structure, biological activity and mechanism of action. | Mol Cell Biochem | 1981 | https://conductscience.org/library/papers/7035868 | PubMed |
| 7,019,079 | Stimulation of nonspecific resistance to infection induced by 6-O-acyl muramyl dipeptide analogs in mice. | Infect Immun | 1981 | https://conductscience.org/library/papers/7019079 | PubMed |
| 6,776,530 | Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine). | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6776530 | PubMed |
| 6,744,667 | Regulation by muramyl dipeptide (MDP) of the lymphoproliferative responses and polyclonal activation of human peripheral blood mononuclear cells. | Clin Exp Immunol | 1984 | https://conductscience.org/library/papers/6744667 | PubMed |
| 6,155,329 | Failure of synthetic muramyl dipeptide to increase antibacterial resistance. | Infect Immun | 1980 | https://conductscience.org/library/papers/6155329 | PubMed |
1 to 10 of 12
See all 12 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/877134
GET https://conductscience.org/api/papers/v1/877134/authors